Pancreatic Cancer Research

ResearcherNorthwestern UniversityActive in the last 2 years

Liang Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3779-7853; OpenAlex author ID A5022634086. Sources: OpenAlex.

Their work

Papers
13 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 3 papers · 2026: 3 papers

Papers 13

  1. Deep learning-based combined noise reduction and contrast enhancement for post-neoadjuvant pancreatic cancer CT: does improved image quality translate to bette… Co-author DOI 10.1007/s00261-025-05271-6↗
  2. Multifrequency magnetic resonance elastography for predicting pancreatic cancer aggressiveness and patient survival. Co-author DOI 10.1007/s00330-026-12824-w↗
  3. Reply to the Letter to the Editor: Peripheral MRE fluidity in pancreatic cancer: considerations on regional sampling and biological interpretation. First author DOI 10.1007/s00330-026-12936-3↗
  4. Looking at or beyond the tumor - a systematic review and meta-analysis of quantitative imaging biomarkers predicting pancreatic cancer prognosis. First author DOI 10.1007/s00261-025-04919-7↗
  5. Comparison of Perfusion CT and Conventional Thin-slice Multiphase CT in the Diagnosis of Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.acra.2025.03.049↗
  6. MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejro.2025.100711↗
  7. Quantitative MR imaging biomarkers for distinguishing inflammatory pancreatic mass and pancreatic cancer-a systematic review and meta-analysis. First author DOI 10.1007/s00330-024-10720-9↗
  8. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice. Co-author DOI 10.1016/j.ebiom.2022.104040↗
  9. Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography. Co-author DOI 10.1007/s00330-020-07420-5↗
  10. Pancreatic cancer with ovarian metastases: A case report and review of the literature. First author DOI 10.12998/wjcc.v8.i21.5380↗
  11. CT Imaging Biomarkers Predict Clinical Outcomes After Pancreatic Cancer Surgery. Co-author DOI 10.1097/md.0000000000002664↗
  12. Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma. First author DOI 10.1371/journal.pone.0116803↗
  13. Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1. First author DOI 10.1007/s11596-011-0673-z↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qi Wang · 2 shared papers, 2026 · strength 0.93
  2. Huadan Xue · 6 shared papers, 2015–2025 · strength 0.93
  3. Zhengyu Jin · 5 shared papers, 2016–2025 · strength 0.88
  4. Menghua Dai · 4 shared papers, 2020–2026 · strength 0.83
  5. Zihe Wang · 2 shared papers, 2024–2025 · strength 0.61
  6. Ingolf Sack · 2 shared papers, 2021–2026 · strength 0.42
  7. Jeongin Yoo · 1 shared paper, 2026 · strength 0.32
  8. Seok Jin Hong · 1 shared paper, 2026 · strength 0.32
  9. Hyo‐Jin Kang · 1 shared paper, 2026 · strength 0.32
  10. Sun Kyung Jeon · 1 shared paper, 2026 · strength 0.32
  11. Jeong Hee Yoon · 1 shared paper, 2026 · strength 0.32
  12. Jeong Min Lee · 1 shared paper, 2026 · strength 0.32
  13. Cheng Ding · 1 shared paper, 2025 · strength 0.30
  14. Xianlin Han · 1 shared paper, 2025 · strength 0.30
  15. F Z Feng · 1 shared paper, 2026 · strength 0.30
  16. Qi Wang · 1 shared paper, 2025 · strength 0.27
  17. Jing-Yi Liu · 1 shared paper, 2025 · strength 0.27
  18. Huanwen Wu · 3 shared papers, 2015–2020 · strength 0.26
  19. Juan Li · 1 shared paper, 2025 · strength 0.22
  20. Yuejuan Cheng · 1 shared paper, 2025 · strength 0.22
  21. Xiaolong Liang · 1 shared paper, 2022 · strength 0.16
  22. Wenjia Zhang · 1 shared paper, 2022 · strength 0.16
  23. Jie Tian · 1 shared paper, 2022 · strength 0.16
  24. Shunda Wang · 1 shared paper, 2020 · strength 0.15
  25. Yu-Pei Zhao · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.